Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1008479

	registered interest
	date	16/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to make flash glucose monitoring technology available to all patients with diabetes across clinical commissioning groups.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	192108
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192109 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1008480

	registered interest
	date	16/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	192109
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1008481

	registered interest
	date	16/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what representations he has received from (a) the public and (b) charities on the benefits of making flash glucose monitoring technology available to all patients with diabetes.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	192110
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192109 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

832935

	registered interest
	date	29/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the take-up rate for cervical screening in (a) York and (b) England.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	125251
	answer	answer is ministerial correction date of answer 06/02/2018 answer text <p>The North Yorkshire and York Health Improvement Plan includes halting the decline in cervical screening coverage by delivering additional training to general practice staff; working with the clinical commissioning group engagement agents and plans to enlist volunteer cancer champions to attend community events and work with local businesses to promote cervical screening.</p><p> </p><p>Public Health England (PHE), the Department and NHS England continue to work together to understand and redress the falling participation in the National Health Service cervical screening programme. A range of work is being undertaken by PHE to understand the reasons for the decline in uptake and to support the NHS and local authorities (LAs) to address them. They include access to timely and useful data for benchmarking, evidence on best practices to increase uptake among women who wish to be screened, using governance levers to advice NHS and LAs and working in partnership with commissioners, providers and charities.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/02/2018 12:06:53 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

835973

	registered interest
	date	02/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Illnesses: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of the proposals in the Life Sciences Strategy on treatments for people with (a) cystic fibrosis and (b) other long-term conditions.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	126328
	answer	answer is ministerial correction date of answer 09/02/2018 answer text <p>No assessment has been made. However, the Government is working in collaboration with the sector to realise the vision of the strategy to ensure the United Kingdom remains a top-tier global hub for clinical research and medical innovation, and ensure that the benefits of these innovations will be felt by UK patients. For example, the Government is investing up to £210 million in an early diagnostics challenge that will help patients benefit from earlier, more accurate diagnosis and more effective treatments. We have also published the response to the Accelerated Access Review which includes the introduction of a new Accelerated Access Pathway and £86 million of funding to support medical innovations get to patients faster.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 09/02/2018 12:08:07 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

850730

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to NHS dental care in (a) York, (b) North Yorkshire and (c) England.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	129970
	answer	answer is ministerial correction date of answer 07/03/2018 answer text <p>NHS England has a legal duty to commission National Health Service dental services to meet the needs of the local population. NHS England also has arrangements in place to help patients who cannot find a local dentist that is accepting new patients.</p><p> </p><p>Access nationally remains high with 22.1 million adults having seen an NHS dentist in the last 24 months ending in 31 December 2017 and 6.9 million children having seen an NHS dentist in the last 12 months. However, there are areas where there is further to go to ensure that all those who want to access NHS dental care can do so.</p><p> </p><p>NHS England (Yorkshire and the Humber) is currently reviewing how it can improve access to NHS dentists from April 2018, prioritising areas where access is particularly difficult.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/03/2018 16:53:33 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

850731

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure all children have access to NHS dental services.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	129971
	answer	answer is ministerial correction date of answer 07/03/2018 answer text <p>NHS England has a legal duty to commission National Health Service dental services to meet the needs of the local population. NHS England also has arrangements in place to help patients who cannot find a local dentist that is accepting new patients.</p><p> </p><p>The proportion of children seeing a dentist at least once a year is already high with 6.8 million children having seen a dentist in the 12 months ending 31 December 2017. This is 110,767 more children than saw a dentist in the 12 month period ending 31 December 2016.</p><p> </p><p>Survey data suggests 75% of children are now decay free at five years old. But there is further to go to ensure all children benefit from this improvement. The proposed new contract being tested includes a clinical pathway which supports dentists to provide the most appropriate preventative care as well as active treatment. Alongside this NHS England is targeting children in areas of particularly high need.</p><p> </p><p>The ‘Starting Well’ programme has been launched in 13 high needs areas and aims to reach children not currently being seen regularly by a dentist. Starting Well core, a complementary programme NHS England is developing, will take the principles of approach and make it available as a broader model to any commissioner based on local assessment of need and priorities. This is expected to be available later in 2018.</p><p><strong> </strong></p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/03/2018 10:31:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

856915

	registered interest
	date	07/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Eating Disorders: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support Clinical Commissioning Groups to meet national standards on the treatment of children and young people with eating disorders.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	131427
	answer	answer is ministerial correction date of answer 14/03/2018 answer text <p>The access and waiting time standard for children and young people with eating disorders states that by 2020/21, evidence-based community eating disorder services for children and young people will be in place in all areas, ensuring that 95% of children in need receive treatment within one week for urgent cases, and four weeks for routine cases.</p><p> </p><p>For children and young people, the latest figures show that the waiting time standard for access to treatment for eating disorders is on track to be met as planned:</p><p>- 76.9% of patients started urgent treatment within one week in Q3 (October - December 2017); and</p><p>- 83.1% of patients started routine treatment within four weeks in Q3 (October – December 2017).</p><p> </p><p>The Department is investing £30 million a year to 2020 to support clinical commissioning groups in developing and enhancing eating disorder services for children and young people. There are now 70 new or expanded community eating disorders services in place.</p><p> </p><p>This funding is to support the commissioning of services to the standards set out in the NHS England and National Collaborating Centre for Mental Health Commissioning Guide, ‘Access and Waiting Time Standard for Children and Young People with an Eating Disorder’, which is available at:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2015/07/cyp-eating-disorders-access-waiting-time-standard-comm-guid.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2015/07/cyp-eating-disorders-access-waiting-time-standard-comm-guid.pdf</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 14/03/2018 15:37:54 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

856916

	registered interest
	date	07/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Eating Disorders
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to introduce (a) access and (b) waiting times standards for adults with eating disorders on an equivalent basis to standards for people up to the age of 19.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	131428
	answer	answer is ministerial correction date of answer 14/03/2018 answer text <p>A pathway for adults with eating disorders, together with detailed implementation guidance for providers, is being developed by the National Collaborating Centre for Mental Health in partnership with the National Institute for Health and Care Excellence. This work will be fully informed by the available evidence and the views of experts by experience.</p><p> </p><p>In parallel to this, a baseline data collection will be undertaken to measure existing levels of investment, capacity and activity across inpatient and community services for adults with eating disorders to assess the feasibility of introducing a mandatory waiting time standard.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 14/03/2018 15:35:26 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

867178

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will bring forward the scheduled review of the Cystic Fibrosis drug Orkambi.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133296
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Government has made no such assessment itself. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE published guidance on the use of Orkambi for the treatment of cystic fibrosis in July 2016 and was not able to recommend it for routine use on the NHS.</p><p> </p><p>NICE has advised that it has not been notified of any new data published in February 2018 related to the use of Orkambi. NICE periodically reviews its technology appraisal guidance to determine whether any new evidence, including new trial data, has emerged that may affect its original recommendations. NICE is next scheduled to review its guidance on the use of Orkambi in July 2019, at which point it will conduct a search for new evidence. NICE’s guidance may be reviewed before the expected review date if significant new evidence emerges that is likely to change the recommendations. The company or any other stakeholder can alert NICE to new evidence in line with its established processes to request an early review.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 133299 question first answered 27/03/2018 11:54:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867181

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made for the implications for its policy of new data published by Vertex Pharmaceuticals in February 2018 on the Cystic Fibrosis drug Orkambi.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133299
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Government has made no such assessment itself. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE published guidance on the use of Orkambi for the treatment of cystic fibrosis in July 2016 and was not able to recommend it for routine use on the NHS.</p><p> </p><p>NICE has advised that it has not been notified of any new data published in February 2018 related to the use of Orkambi. NICE periodically reviews its technology appraisal guidance to determine whether any new evidence, including new trial data, has emerged that may affect its original recommendations. NICE is next scheduled to review its guidance on the use of Orkambi in July 2019, at which point it will conduct a search for new evidence. NICE’s guidance may be reviewed before the expected review date if significant new evidence emerges that is likely to change the recommendations. The company or any other stakeholder can alert NICE to new evidence in line with its established processes to request an early review.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 133296 question first answered 27/03/2018 11:54:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867182

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions has his Department had with Cystic Fibrosis sufferers on the provision of the drug Orkambi by the NHS.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133300
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Government met with the Cystic Fibrosis Trust, which represents patients with cystic fibrosis, in March 2017 to discuss access to the drug Orkambi. The Government has also had regular correspondence with patients with cystic fibrosis concerning the availability of Orkambi. We are also aware that NHS England has been in regular contact with the Cystic Fibrosis Trust about this matter.</p><p> </p><p>The Government welcomes the ongoing discussions between NHS England and the manufacturer of Orkambi, Vertex, to seek to agree a deal that would make Orkambi available to National Health Service patients in a way that represents value to the taxpayer.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 11:56:18 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867387

	registered interest
	date	20/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential reduction in hospital admissions for people with cystic fibrosis were Orkambi to be made available on the NHS.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133362
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Department has made no assessment itself. However, in developing its technology appraisal guidance, the National Institute for Health and Care Excellence, takes into account all the costs and savings associated with the treatment compared with existing clinical practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 14:32:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867419

	registered interest
	date	20/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential savings to the public purse from the health service encouraging the uptake of e-cigarettes among smokers.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133394
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The potential financial impacts of e-cigarettes on the public purse are not yet fully understood. The evidence base is still evolving on these products, largely because vaping is still relatively new and the health effects may be very long term. Significant savings to the public purse are likely to arise only if smokers switch completely from smoked tobacco. The Government’s Tobacco Control Plan, published in July 2017, estimates that the National Health Service currently spends £2.5 billion on treating smoking-related diseases and Public Health England assess e-cigarettes to be at least 95% less harmful than smoked tobacco. Reduced harm may not translate exactly into proportional costs savings, but superficially this implies that vaping, as an alternative to smoking, may contribute to significant savings.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 14:37:44 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867420

	registered interest
	date	20/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage smokers to give up by promoting the use of e-cigarettes.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133395
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Department has been clear that for smokers, quitting smoking completely is the best way to improve health. E-cigarettes are not risk free. However, the evidence is increasingly clear that e-cigarettes are significantly less harmful to health than cigarettes and can help smokers to quit, particularly when combined with support from stop smoking services.</p><p> </p><p>The Government committed Public Health England (PHE), through the Tobacco Control Plan, published in 2017, to include messages about the relative safety of e-cigarettes in their quit smoking campaigns. PHE’s 2017 Stoptober campaign included e-cigarettes among the array of tools that smokers can use to help them quit and, in their New Year smoking health harms campaign, PHE reprised these messages. It is through this consistent messaging that the Government hopes to reverse the harmful, mistaken – and increasingly widespread – belief that vaping is no safer than smoking.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 14:42:47 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

886331

	registered interest
	date	18/04/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Eating Disorders
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the NHS in implementing early intervention measures for people who have eating disorders.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	136526
	answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The Government recognises that early intervention is absolutely vital and is committed to ensuring everyone with an eating disorder has access to timely treatment.</p><p> </p><p>For children and young people, the Government set up the first waiting times to improve access to eating disorders services for children and young people - so that by 2020/21 95% of children with an eating disorder will receive treatment within one week for urgent cases and within four weeks for routine cases. Latest figures indicate that the National Health Service is on track to meet that standard with almost 76.9% of all patients starting urgent treatment within one week and 83.1% of patients starting routine treatment within four weeks (third quarter of 2017-2018). The data is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/cyped-waiting-times/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/cyped-waiting-times/</a></p><p> </p><p>The Government announced in 2014 that it would invest £150 million to expand eating disorder community-based care and as a result 70 dedicated new or extended community services are now either open or in development. This means at least 3,350 children and young people a year will receive swift, effective eating disorder treatment in the community.</p><p> </p><p>For adults, a care pathway together with detailed implementation guidance for providers is under development by the National Collaborating Centre for Mental Health in partnership with the National Institute for Health and Care Excellence. The pathway is being fully informed by the available evidence and the views of experts and will increase healthcare professionals’ awareness of the early signs and symptoms of eating disorders so that they are able to refer without delay and intervene early.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/04/2018 12:52:47 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

906365

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Acupuncture
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of acupuncture on the NHS in each Clinical Commissioning Groups in England.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	145325
	answer	answer is ministerial correction date of answer 23/05/2018 answer text <p>No such assessment has been made. It is the responsibility of clinical commissioning groups to make decisions on the commissioning and funding of any health care treatments for National Health Service patients, such as acupuncture, taking account of issues to do with safety, clinical and cost-effectiveness and the availability of suitably qualified or regulated practitioners.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/05/2018 15:37:33 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

917471

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the oral evidence given by the Prime Minister to the Liaison Committee on 27 March 2018, what share of funds he plans to allocate to general practice under the multi-year NHS funding settlement; and if he will make a statement.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150087
	answer	answer is ministerial correction date of answer 13/06/2018 answer text <p>My Rt. hon. Friend the Prime Minister announced, in her evidence to the Liaison Committee on 27 March, her intention to come forward with a long-term plan for the National Health Service, supported by a multi-year financial settlement to deliver that plan. The Government will bring forward a long-term plan this year, in advance of the Spending Review. The Government will work with NHS leaders, clinicians and experts to develop this long-term plan, to ensure that the NHS can cope with the serious demand and cost pressures it faces in the future.</p><p> </p><p>No decision has yet been taken on the share of funds to be allocated to general practice under the multi-year financial settlement.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 13/06/2018 14:15:23 answering member 4095 label Biography information for Steve Barclay
	tabling member	4079 label Biography information for Julian Sturdy

917472

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle GP workload.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150088
	answer	answer is ministerial correction date of answer 13/06/2018 answer text <p>We are tackling general practitioner (GP) workload by investing in the Releasing Time to Care Programme and expanding the skill mix in general practice. The Releasing Time for Care Programme is designed to help practices implement change to release time more quickly and sustainably. As of October 2017 a series of workshops have reached around 4,800 participants, and survey responses suggest that attending the workshop has had an immediate and substantial effect on practices’ optimism.</p><p> </p><p>We are widening the skills mix by investing in the wider general practice workforce in extra mental health therapists, clinical pharmacists, general practice nurse development, training of current reception and clerical staff, training of physician associates, pilots of new medical assistant roles, and practice manager development nationwide to free up valuable GP time.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/06/2018 15:33:45 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

917473

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Yorkshire and the Humber
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP trainees began training in (a) York and (b) Yorkshire and the Humber in the most recent year for which statistics are available.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150089
	answer	answer is ministerial correction date of answer 12/06/2018 answer text <p>We do not hold data on the number of general practitioner (GP) trainees who started training in York and Yorkshire and the Humber. The number of GP registrars working in general practice in the Vale of York Clinical Commissioning Group and NHS England North (Yorkshire and the Humber) in September 2017 is presented in the following table. This may not represent all trainee GPs in these regions as they do not spend the entirety of their training as a GP registrar working in general practice. The remaining time is spent training in hospitals.</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>GP Registrars (Full Time Equivalent (FTE))</p></td><td><p>GP Registrars (Headcount)</p></td></tr><tr><td><p>NHS Vale of York CCG</p></td><td><p>12</p></td><td><p>13</p></td></tr><tr><td><p>NHS England North (Yorkshire and Humber)</p></td><td><p>244</p></td><td><p>277</p></td></tr></tbody></table><p> </p><p>Notes:</p><p><strong> </strong></p><p>1. Figures contain estimates for the 5.4% of practices that did not provide fully valid GP data.</p><p> </p><p>2. FTE refers to the proportion of full time contracted hours that the post holder is contracted to work. 1 would indicate they work a full set of hours, 0.5 that they worked half time.</p><p> </p><p>3. Figures shown do not include GPs working in Prisons, Army Bases, Educational Establishments, Specialist Care Centres including Drug Rehabilitation Centres and Walk-In Centres.</p><p> </p><p>Data as at 30 September</p><p> </p><p>Source: NHS Digital</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/06/2018 15:17:21 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

917475

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP trainers were registered in York in the most recent year for which information is available; and how many were so registered five years ago.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150090
	answer	answer is ministerial correction date of answer 12/06/2018 answer text <p>The York general practitioner (GP) specialty training scheme is well established, respected, evaluated and popular with those choosing to train to become GPs. It attracted higher than regional-average fill rates in the last round of GP recruitment. The scheme has three experienced training programme directors (TPD) that are responsible for the support and delivery of teaching and training for trainees at weekly group sessions, as well as the planning and delivery of training rotations in the area, and support for local GP trainers. The ratio of TPD sessions to trainees is higher than the average for Yorkshire and the Humber.</p><p> </p><p>The training scheme usually operates from postgraduate education centre at York District Hospital. There have been recent renovations to this facility and there is a current period of adaptation and re-organisation, which Health Education England is supporting locally, to make the facilities ideal for all parties.</p><p> </p><p>GP trainers are responsible for the day-to-day supervision of trainee GPs who are on placements in practices. In the year August 2016 to July 2017 there were 34 headcount GP trainers linked to the York GP Speciality Training Programme. Data held prior to this period is not comparable.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 150091 question first answered 12/06/2018 15:25:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

917476

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure there are appropriate GP training facilities in York.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150091
	answer	answer is ministerial correction date of answer 12/06/2018 answer text <p>The York general practitioner (GP) specialty training scheme is well established, respected, evaluated and popular with those choosing to train to become GPs. It attracted higher than regional-average fill rates in the last round of GP recruitment. The scheme has three experienced training programme directors (TPD) that are responsible for the support and delivery of teaching and training for trainees at weekly group sessions, as well as the planning and delivery of training rotations in the area, and support for local GP trainers. The ratio of TPD sessions to trainees is higher than the average for Yorkshire and the Humber.</p><p> </p><p>The training scheme usually operates from postgraduate education centre at York District Hospital. There have been recent renovations to this facility and there is a current period of adaptation and re-organisation, which Health Education England is supporting locally, to make the facilities ideal for all parties.</p><p> </p><p>GP trainers are responsible for the day-to-day supervision of trainee GPs who are on placements in practices. In the year August 2016 to July 2017 there were 34 headcount GP trainers linked to the York GP Speciality Training Programme. Data held prior to this period is not comparable.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 150090 question first answered 12/06/2018 15:25:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

922333

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increased uniformity of medication packaging across manufacturers to enable the efficient identification of all medicines.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	152755
	answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.</p><p> </p><p>While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.</p><p> </p><p>Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 152756 152757 question first answered 20/06/2018 16:03:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

922337

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what representations he has received on the desirability of increased uniformity of medication packaging across manufacturers from the (a) public and (b) health service.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	152756
	answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.</p><p> </p><p>While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.</p><p> </p><p>Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 152755 152757 question first answered 20/06/2018 16:03:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy

922344

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the implications for the safety of patients of the variety in packaging of the same medicines; and if he will make a statement.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	152757
	answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>The Government has produced guidance in conjunction with experts in clinical practice and in the field of design for those who produce medicines packaging which recommends the judicious use of colour to ensure medicines are well differentiated to reduce the likelihood of error. In developing the principles within this guidance, the views of healthcare professionals and patients have been considered.</p><p> </p><p>While there are detailed legal requirements with respect to the content of the information provided on the packaging there are no provisions with respect to colour and design of the packaging when presented to the market place.</p><p> </p><p>Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing. Where specific safety issues have been identified, for example with medicines containing warfarin, particular colours both for the tablets and the packaging have been adopted as an industry standard.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 152755 152756 question first answered 20/06/2018 16:03:25 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4079 label Biography information for Julian Sturdy